Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1931-1940 of 2905 for cancer

Edit search filters
  1. Testing The Effects Of MK-3475 (Pembrolizumab) With Or Without The Usual Chemotherapy Treatment For Patients 70 Years Of Age And Older With Advanced Non-small Cell Lung Cancer

    Eau Claire, WI, La Crosse, WI

  2. Combination Of Serabelisib And Insulin Suppressing Diet In Subjects With Advanced Solid Tumors With PIK3CA Mutations

    Rochester, MN

  3. A Study Of Ruxolitinib For The Treatment Of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

    Rochester, MN

  4. Pembrolizumab Plus Epacadostat Alone Or With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo In Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-02/ECHO-306)

    Rochester, MN

  5. A Study To Assess The Effectiveness And Safety Of UGN-102 As A Primary Chemoablation Agent In Patients With Low Grade Non-Muscle-Invasive Bladder Cancer (LG NMIBC) At Intermediate Risk Of Recurrence

    Scottsdale/Phoenix, AZ

  6. A Study To Compare The Combination Of Navlimetostat (BMS-986504) With Pembrolizumab And Chemotherapy Versus Placebo Plus Pembrolizumab And Chemotherapy In First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study Of MPDL3280A (Anti-PD-L1 Antibody) Combined With Carboplatin And Paclitaxel , And With Or Without Bevacizumab, For Patients Who Have Stage IV Non-Squamous Non-Small Cell Lung Cancer

    Jacksonville, FL

  8. A Study To Compare Whole Brain Radiotherapy And Memantine To Stereotactic Radiosurgery Vs. Stereotactic Radiosurgery Alone To Treat Patients With Cancer That Has Spread To The Brain After Earlier Stereotactic Radiosurgery

    Jacksonville, FL

  9. Study Of Radium-223 Dichloride Versus Placebo And Hormonal Treatment As Background Therapy In Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer

    Rochester, MN

  10. Study Of Radium-223 Dichloride Versus Placebo And Treatment With Exemestane / Everolimus In Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer

    Rochester, MN

.

Mayo Clinic Footer